Repeat ECG in 15-30 minutes (or with any change in symptoms).
Initiate standard evaluation and treatment (e.g., Aspirin).
High-Risk Pathway: NSTE-ACS Evaluation
The ECG is concerning. Are the patient's symptoms also suggestive of a NSTE-ACS?
High-Risk Pathway: Hemodynamic Stability
After initiating NSTE-ACS workup, first assess for hemodynamic instability. Does the patient have any signs of hemodynamic instability?
Examples of Hemodynamic Instability:
Hypotension (Systolic BP < 90, MAP < 65)
Tachypnea (RR > 30)
Increased work of breathing (e.g., sweating, sitting up)
High-Risk Pathway: Troponin Evaluation
Is the high-sensitivity troponin (hs-cTn) elevated on the initial or 2-hour repeat draw?
High-Risk Pathway: Final Safety Check
Despite the initial high-risk ECG, the troponins are negative. Is the patient now clinically stable?
Confirm ALL of the following are true:
Repeat ECG is unchanged or improved.
Chest pain is resolved.
2-hour hs-cTn is negative/normal.
Outcome: Consider Other Diagnoses
Work up other causes of chest pain with ischemic ECG changes (PE, dissection, pericarditis, sepsis, etc.). This may require observation or admission.
Outcome: High-Risk NSTE-ACS
Patient is high-risk due to hemodynamic instability, elevated troponin, or ongoing signs/symptoms. Consult Cardiology fellow for recommendations, consideration of LHC/PCI, and subsequent admission.
Step 4: Main Clinical Decision Pathway
The patient has no STEMI and no other concerning ischemic ECG changes. They are a candidate for the main pathway using hs-cTn and the HEART Score.
Step 4a: Symptom Onset
Did symptoms start ≥ 3 hours before the initial hs-cTn was drawn?
Single-Draw Pathway
Is the initial hs-cTn < 3 ng/L?
Step 4b: Evaluate hs-cTn Results
Which criteria do the initial and 2-hour delta hs-cTn results meet?
Myocardial Injury: Evaluate Cause
The troponin is significantly elevated. Does the clinical picture suggest this is a primary Type 1 NSTEMI?
Outcome: Consult Cardiology for NSTEMI
Patient has findings concerning for a Type 1 NSTEMI. Consult Cardiology fellow for recommendations and admission.
Outcome: Admit for Undifferentiated Injury
Patient has undifferentiated myocardial injury not felt to be a primary Type 1 NSTEMI. Consult Medicine for admission and further workup.
Step 4c: HEART Score Calculator
Calculate the patient's HEART score to determine disposition for the Gray Zone.
Total Score: 0
Intermediate Risk Pathway (HEART 4-6)
The patient has an Intermediate Risk HEART score. Engage in Shared Decision Making about the next steps.
High Risk Pathway (HEART ≥7)
The patient has a High Risk HEART score and requires either observation or admission.
Step 5: Disposition Planning
This patient requires further evaluation beyond the initial ED workup. Is an ED Observation unit available for this patient?
Outcome: Low-Risk / Rapid Rule-Out Discharge
Patient meets low-risk criteria. Discharge home with Primary Care (PDC) follow-up within 14 days.
Final Discharge Considerations:
ED Clinical judgment (consider other etiologies)
Is chest pain improving or resolved?
Is a repeat 2 hour ECG unchanged?
Documentation Reminder: A HEART score should be documented for all chest pain patients.
Outcome: Discharge via Shared Decision
Patient is intermediate-risk and a shared decision was made to discharge. Discharge home with Primary Care (PDC) follow-up within 7 days.
Final Discharge Considerations:
ED Clinical judgment (consider other etiologies)
Is chest pain improving or resolved?
Is a repeat 2 hour ECG unchanged?
Outcome: Place in ED Observation
The patient meets criteria for observation status. Initiate the ED Observation protocol for further monitoring and/or non-invasive testing as per unit guidelines.
Outcome: Admit to Medicine
The patient requires inpatient admission. Consult the hospital medicine service for admission and further management.